Li Y - Search Results

1

Successful treatment of two patients with unresectable lung squamous cell carcinoma with tislelizumab regardless of programmed death-ligand 1 expression: a report of two cases.

Wu Q, Cao Y, Li Y, Jiang N, Dong H, Dong Y, Chen F, Yue G, Luo Q. Wu Q, et al. Among authors: li y. Anticancer Drugs. 2022 Jan 1;33(1):e828-e833. doi: 10.1097/CAD.0000000000001238. Anticancer Drugs. 2022. PMID: 34459453 Free PMC article.

2

Distribution of CD8 T Cells and NK Cells in the Stroma in Relation to Recurrence or Metastasis of Nasopharyngeal Carcinoma.

Li Y, Dong H, Dong Y, Wu Q, Jiang N, Luo Q, Chen F. Li Y, et al. Cancer Manag Res. 2022 Sep 27;14:2913-2926. doi: 10.2147/CMAR.S365230. eCollection 2022. Cancer Manag Res. 2022. PMID: 36193054 Free PMC article.

3

LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Gan FJ, Li Y, Xu MX, Zhou T, Wu S, Hu K, Li Y, Sun SH, Luo Q. Gan FJ, et al. Among authors: li y. Cancer Biomark. 2021;32(3):339-351. doi: 10.3233/CBM-210048. Cancer Biomark. 2021. PMID: 34151842 Free PMC article.

4

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC.

Jiang L, Guo F, Liu X, Li X, Qin Q, Shu P, Li Y, Wang Y. Jiang L, et al. Among authors: li y, li x. Sci Rep. 2019 Mar 6;9(1):3705. doi: 10.1038/s41598-018-38068-3. Sci Rep. 2019. PMID: 30842489 Free PMC article.

5

Identification of a Metastasis-Related Protein IFI16 in Esophageal Cancer using a Proteomic Approach.

Wang Z, Sheng B, Wei Z, Li Y, Liu Z. Wang Z, et al. Among authors: li y. J Cancer. 2022 Mar 6;13(5):1630-1639. doi: 10.7150/jca.59286. eCollection 2022. J Cancer. 2022. PMID: 35371314 Free PMC article.

6

[Silencing Effect of APE1 on the Radiosensitivity of Non-small Cell Lung Cancer Cells].

Ou YH, Li Y, Liu Q, Wang YS. Ou YH, et al. Among authors: li y. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019 Jan;50(1):1-6. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31037897 Chinese.

7

Crizotinib enhances anti-CD30-LDM induced antitumor efficacy in NPM-ALK positive anaplastic large cell lymphoma.

Wang R, Li L, Duan A, Li Y, Liu X, Miao Q, Gong J, Zhen Y. Wang R, et al. Among authors: li y, li l. Cancer Lett. 2019 Apr 28;448:84-93. doi: 10.1016/j.canlet.2019.02.002. Epub 2019 Feb 8. Cancer Lett. 2019. PMID: 30742941

8

Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma.

Li Y, Yang B, Ma Y, Peng X, Wang Z, Sheng B, Wei Z, Cui Y, Liu Z. Li Y, et al. Signal Transduct Target Ther. 2021 Nov 12;6(1):381. doi: 10.1038/s41392-021-00682-5. Signal Transduct Target Ther. 2021. PMID: 34764241 Free PMC article. No abstract available.

9

FZR1 as a novel biomarker for breast cancer neoadjuvant chemotherapy prediction.

Liu S, Wang H, Li J, Zhang J, Wu J, Li Y, Piao Y, Pan L, Xiang R, Yue S. Liu S, et al. Among authors: li y, li j. Cell Death Dis. 2020 Sep 25;11(9):804. doi: 10.1038/s41419-020-03004-9. Cell Death Dis. 2020. PMID: 32978372 Free PMC article.

10

Emerging agents and regimens for multiple myeloma.

Yang Y, Li Y, Gu H, Dong M, Cai Z. Yang Y, et al. Among authors: li y. J Hematol Oncol. 2020 Nov 9;13(1):150. doi: 10.1186/s13045-020-00980-5. J Hematol Oncol. 2020. PMID: 33168044 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240,818 results

Search Page

Filters